http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5951791-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5128cfc84a0fb189fceb3cd240c44493 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12 |
| filingDate | 1982-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9009d013ab98beaab3ce920b0fa979ba |
| publicationDate | 1984-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S5951791-A |
| titleOfInvention | Cell fusion |
| abstract | PURPOSE:To prepare a hybrid cell strain in high efficiency, by synchronizing each period of at least one cell strain with G1 period after cell division, carrying out cell fusion. CONSTITUTION:In preparing a hybrid cell strain by cell fusion between cell strains or from a cell strain and a normal cell, at least one cell strain is cultivated previously in the presence of an inhibitor for cell growth such as indomethacin, etc. only for a time required for one cell division, the inhibitor for cell growth is then removed, the cultivation is continued, an agent for cell fusion is added to the cell strain after 1-3 cell divisions, preferably at G1 period after one cell division, and cell fusion is carried out. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046033-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8216842-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010511379-A |
| priorityDate | 1982-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247 |
Total number of triples: 17.